Panorama Medicine Inc
Philadelphia, PA · Founded 2018 · CIK 0001775212 · Biotech · Private
PANOPLY platform: AI/ML system that analyzes genetic sequencing data to predict disease-causing RNA splice events across 53 tissues, combined with a proprietary screening platform to identify small-mo
panoramamedicine.com →- Grants
- $668K
- 2 awards
- Sector median: 1
- Raised
- $4.7M
- 3 Form D · Jan 2021
- 68 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $2,150,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Computational prediction of RNA splicing defects and rescue by small-molecule therapeutics | $333,843 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Computational prediction of RNA splicing defects and rescue by small-molecule therapeutics | $333,843 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2505 | VIVOVERSE, LLC | — | — |
| 2506 | Kamau Therapeutics, Inc. | — | $5.0M |
| 2507 | CONFLUENCE LIFE SCIENCES, INC. | — | $5.7M |
| 2508 | Panorama Medicine Inc | — | $4.7M |
| 2509 | GENEDIT INC | — | — |
| 2510 | DUO ONCOLOGY INC | — | $4.2M |
| 2511 | Synthekine | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Yi-Yen ChenDirector
- Maxine GowenDirector
- Jimmy LuDirector
- Yi XingDirector
- Mingfu ZhuDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.